Seeking Alpha

Mark S. Anderson

 
View as an RSS Feed
View Mark S. Anderson's Articles BY TICKER:
  • Why They Have It Wrong About Zogenix And You Would Be Right To Buy
    Tue, Mar. 25 ZGNX 34 Comments

    Summary

    • Zohydro is the least potent of the extended-release painkillers.
    • ZGNX's 52-week high is $5.19, currently more than a 40% drop to $3.04 on misinformation being released.
    • One of the only two extended-release painkillers that achieved less than 2% adverse effects.